Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaasFlex dapagliflozin crossover study
2018-003283-31Phase 4Completed
- Sponsor
- NUTRIM
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dapagliflozin in impaired glucose homeostasis (2 arms), sponsored by NUTRIM. Started Dec 2018; status: completed.
02
Drugs
dapagliflozin
03
Conditions
impaired glucose homeostasis
Beyond the preview
Go deeper on 2018-003283-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003283-31.